Annual long term liabilities:
$2.21B-$1.04B(-31.95%)Summary
- As of today (August 16, 2025), TAK annual total long term liabilities is $2.21 billion, with the most recent change of -$1.04 billion (-31.95%) on March 1, 2025.
- During the last 3 years, TAK annual long term liabilities has fallen by -$4.35 billion (-66.29%).
- TAK annual long term liabilities is now -80.54% below its all-time high of $11.36 billion, reached on March 31, 2019.
Performance
TAK Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$34.37B+$2.26B(+7.03%)Summary
- As of today (August 16, 2025), TAK quarterly total long term liabilities is $34.37 billion, with the most recent change of +$2.26 billion (+7.03%) on June 1, 2025.
- Over the past year, TAK quarterly long term liabilities has dropped by -$2.68 billion (-7.24%).
- TAK quarterly long term liabilities is now -44.39% below its all-time high of $61.81 billion, reached on June 30, 2019.
Performance
TAK quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TAK Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.9% | -7.2% |
| 3 y3 years | -66.3% | -15.9% |
| 5 y5 years | -78.0% | -37.2% |
TAK Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.3% | at low | -15.9% | +7.0% |
| 5 y | 5-year | -78.0% | at low | -39.9% | +7.0% |
| alltime | all time | -80.5% | +342.2% | -44.4% | +1352.9% |
TAK Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $34.37B(+7.0%) |
| Mar 2025 | $2.21B(-32.0%) | $32.12B(-9.8%) |
| Dec 2024 | - | $35.60B(-3.4%) |
| Sep 2024 | - | $36.86B(-0.5%) |
| Jun 2024 | - | $37.06B(+1.6%) |
| Mar 2024 | $3.25B(-34.3%) | $36.48B(-1.0%) |
| Dec 2023 | - | $36.86B(+1.3%) |
| Sep 2023 | - | $36.37B(-1.9%) |
| Jun 2023 | - | $37.08B(-3.5%) |
| Mar 2023 | $4.95B(-24.5%) | $38.43B(-1.0%) |
| Dec 2022 | - | $38.83B(+2.3%) |
| Sep 2022 | - | $37.96B(-7.1%) |
| Jun 2022 | - | $40.86B(-6.8%) |
| Mar 2022 | $6.56B(-24.7%) | $43.82B(-9.3%) |
| Dec 2021 | - | $48.29B(+1.7%) |
| Sep 2021 | - | $47.50B(-8.1%) |
| Jun 2021 | - | $51.67B(-4.4%) |
| Mar 2021 | $8.71B(-13.2%) | $54.04B(-4.6%) |
| Dec 2020 | - | $56.64B(-0.9%) |
| Sep 2020 | - | $57.14B(+4.4%) |
| Jun 2020 | - | $54.76B(-0.0%) |
| Mar 2020 | $10.03B(-11.7%) | $54.76B(-1.1%) |
| Dec 2019 | - | $55.35B(-6.3%) |
| Sep 2019 | - | $59.06B(-4.5%) |
| Jun 2019 | - | $61.81B(+13.2%) |
| Mar 2019 | $11.36B(+283.8%) | $54.60B(+111.2%) |
| Dec 2018 | - | $25.85B(+133.6%) |
| Sep 2018 | - | $11.07B(-10.0%) |
| Jun 2018 | - | $12.30B(-3.3%) |
| Mar 2018 | $2.96B(-14.1%) | $12.72B(+2.5%) |
| Dec 2017 | - | $12.40B(-2.5%) |
| Sep 2017 | - | $12.72B(+4.1%) |
| Jun 2017 | - | $12.22B(+32.5%) |
| Mar 2017 | $3.45B(+6.1%) | $9.23B(-5.9%) |
| Dec 2016 | - | $9.80B(-11.0%) |
| Sep 2016 | - | $11.00B(+0.6%) |
| Jun 2016 | - | $10.94B(+28.7%) |
| Mar 2016 | $3.25B(-8.9%) | $8.50B(+0.8%) |
| Dec 2015 | - | $8.43B(-3.3%) |
| Sep 2015 | - | $8.72B(-0.8%) |
| Jun 2015 | - | $8.79B(-1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | $3.57B(-27.5%) | $8.94B(-14.0%) |
| Dec 2014 | - | $10.40B(-9.8%) |
| Sep 2014 | - | $11.53B(-5.9%) |
| Jun 2014 | - | $12.25B(+2.9%) |
| Mar 2014 | $4.92B(-8.9%) | $11.91B(-10.2%) |
| Dec 2013 | - | $13.26B(-4.5%) |
| Sep 2013 | - | $13.89B(+22.9%) |
| Jun 2013 | - | $11.31B(-1.5%) |
| Mar 2013 | $5.40B(+2.0%) | $11.47B(-9.4%) |
| Dec 2012 | - | $12.66B(-3.9%) |
| Sep 2012 | - | $13.17B(+32.1%) |
| Jun 2012 | - | $9.97B(+20.8%) |
| Mar 2012 | $5.29B(+122.9%) | $8.25B(+52.9%) |
| Dec 2011 | - | $5.40B(-5.2%) |
| Sep 2011 | - | $5.69B(+121.3%) |
| Jun 2011 | - | $2.57B(+0.5%) |
| Mar 2011 | $2.37B(+6.7%) | $2.56B(-1.7%) |
| Dec 2010 | - | $2.61B(-0.6%) |
| Sep 2010 | - | $2.62B(+0.3%) |
| Jun 2010 | - | $2.61B(+6.3%) |
| Mar 2010 | $2.23B(+7.0%) | $2.46B(+3.9%) |
| Dec 2009 | - | $2.37B(-3.8%) |
| Sep 2009 | - | $2.46B(+4.0%) |
| Mar 2009 | $2.08B(+124.0%) | $2.37B(-5.0%) |
| Dec 2008 | - | $2.49B |
| Mar 2008 | $928.17M(-26.1%) | - |
| Mar 2007 | $1.26B(+4.1%) | - |
| Mar 2006 | $1.21B(+0.7%) | - |
| Mar 2005 | $1.20B(-9.0%) | - |
| Mar 2004 | $1.32B(+53.8%) | - |
| Mar 2003 | $855.73M(-11.5%) | - |
| Mar 2002 | $966.59M(-14.1%) | - |
| Mar 2001 | $1.13B(+77.6%) | - |
| Mar 2000 | $633.64M(-26.3%) | - |
| Mar 1999 | $859.99M(+72.0%) | - |
| Mar 1998 | $500.05M(-41.3%) | - |
| Mar 1997 | $851.16M(+33.2%) | - |
| Mar 1996 | $639.02M(-50.6%) | - |
| Mar 1995 | $1.29B(+22.8%) | - |
| Mar 1994 | $1.05B(-12.1%) | - |
| Mar 1993 | $1.20B(+50.0%) | - |
| Mar 1992 | $798.96M | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total long term liabilities?
- What is the all time high annual long term liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual long term liabilities year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly long term liabilities year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total long term liabilities?
The current annual long term liabilities of TAK is $2.21B
What is the all time high annual long term liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total long term liabilities is $11.36B
What is Takeda Pharmaceutical Company Limited annual long term liabilities year-on-year change?
Over the past year, TAK annual total long term liabilities has changed by -$1.04B (-31.95%)
What is Takeda Pharmaceutical Company Limited quarterly total long term liabilities?
The current quarterly long term liabilities of TAK is $34.37B
What is the all time high quarterly long term liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total long term liabilities is $61.81B
What is Takeda Pharmaceutical Company Limited quarterly long term liabilities year-on-year change?
Over the past year, TAK quarterly total long term liabilities has changed by -$2.68B (-7.24%)